Spironolactone Cost in New York: Cash Prices, Insurance, and Savings in 2026

How Much Does Spironolactone Cost in New York in 2026?
At a glance
- Average NY cash price (2026) / $15 per month for generic oral tablets
- Manufacturer list price / $80 per month (Pfizer branded and generic equivalents)
- New York Medicaid / Covered with prior authorization
- Compounded spironolactone / Legal via 503A pharmacies under NY Board of Pharmacy oversight
- Telehealth prescribing / Fully legal in New York
- Typical dose form / 25 mg to 200 mg oral tablet, taken once or twice daily
- Prescription status / Prescription only; no OTC path
- FDA-approved indications / Heart failure, edema, primary hyperaldosteronism, hypokalemia
- Off-label acne use / Supported by clinical evidence; not FDA-approved for acne
Cash Prices at New York Retail Pharmacies
The average cash price for a 30-day supply of generic spironolactone across New York retail pharmacies sits around $15 in 2026. That figure applies to the most commonly prescribed strengths (25 mg, 50 mg, and 100 mg tablets) and reflects pricing at major chains including CVS, Walgreens, Rite Aid, and independent pharmacies across all five boroughs and upstate regions.
Pfizer's branded version and some generic equivalents carry a manufacturer list price near $80 per month, but few patients pay that amount. Generic competition has pushed the actual shelf price well below list. Prices can vary by $5 to $10 depending on your borough and pharmacy. Manhattan pharmacies sometimes charge a slight premium over outlets in the Bronx, Queens, or suburban Westchester locations.
The FDA-approved labeling for spironolactone lists indications for heart failure with reduced ejection fraction, edema associated with cirrhosis, nephrotic syndrome, and primary hyperaldosteronism. Dermatologic use for hormonal acne remains off-label, which affects both coverage and out-of-pocket dynamics. Off-label status does not change the pharmacy retail price, but it can complicate insurance approval.
For patients paying cash, the drug ranks among the least expensive prescription acne treatments available in New York. A month of isotretinoin, by comparison, can run $200 to $400 without insurance, and branded topical retinoids often exceed $300 per tube at full price. Spironolactone's low baseline cost is one reason dermatologists favor it as a first-line hormonal therapy for adult female acne.
New York Medicaid Coverage for Spironolactone
New York Medicaid covers spironolactone, but the program requires prior authorization (PA). That PA step exists because the most common dermatologic uses (hormonal acne and hirsutism) are off-label. Prescribers must document that the patient meets clinical criteria, which typically means a diagnosis of moderate-to-severe hormonal acne in a female patient who has not responded adequately to topical therapy alone.
A 2017 systematic review by Layton et al. published in the British Journal of Dermatology examined the evidence base for spironolactone in female acne. The review found that spironolactone at doses of 50 mg to 200 mg daily produced clinically meaningful improvement in acne severity across multiple studies. This body of evidence is what most prescribers reference when building a PA request.
The PA turnaround in New York Medicaid generally takes 24 to 72 hours for electronic submissions. Paper submissions can take up to two weeks. If approved, the copay is $0 to $3 for most Medicaid managed care plans, including Fidelis Care, Healthfirst, MetroPlus, and Amerigroup. Patients enrolled in straight Medicaid (fee-for-service) pay $0 for generic drugs.
One practical consideration: if a PA is denied, New York Medicaid's fair hearing process allows patients to appeal. The denial letter will include instructions. Prescribers can also submit a letter of medical necessity citing the Layton review and the patient's treatment history. Most denials stem from insufficient documentation rather than outright policy exclusion, and resubmission with proper records usually resolves the issue.
Insurance Coverage Across New York Plans
Beyond Medicaid, most commercial insurance plans available through the New York State of Health marketplace and employer-sponsored plans cover generic spironolactone on their formularies. It typically sits on Tier 1 (preferred generic), which means copays of $0 to $15 per month depending on the specific plan.
Major New York insurers, including Empire BlueCross BlueShield, UnitedHealthcare, Aetna, Cigna, and Oscar Health, list generic spironolactone as a covered generic. The drug's low acquisition cost means insurers have little financial incentive to restrict access for on-label indications like heart failure or hypertension. Off-label prescriptions for acne may still require a PA on certain plans, particularly those with dermatology-specific step therapy requirements.
Step therapy protocols are worth understanding. Some plans require documentation that the patient tried and failed at least one topical retinoid and one topical or oral antibiotic before approving spironolactone for acne. The American Academy of Dermatology's acne guidelines support spironolactone as a treatment option for adult women with hormonal acne, which strengthens PA submissions.
Patients with high-deductible health plans (HDHPs) may find that the cash price of $15 is actually lower than the "insurance price" applied before meeting their deductible. In that scenario, asking the pharmacist to run the prescription as cash-pay rather than through insurance is a straightforward way to save money. This is legal and common practice.
Compounded Spironolactone in New York: Legality and Access
Compounded spironolactone is legal in New York when dispensed by a licensed 503A compounding pharmacy operating under New York State Board of Pharmacy oversight. Section 503A of the Federal Food, Drug, and Cosmetic Act permits patient-specific compounding based on a valid prescription, and New York state law aligns with these federal requirements.
Compounded formulations are most relevant for two groups of patients. First, those who need a non-standard dose (for example, 75 mg, which is not commercially available as a single tablet). Second, patients who need a topical formulation of spironolactone for localized acne treatment or who cannot tolerate oral tablets due to gastrointestinal side effects.
Topical spironolactone compounded at 5% concentration has been studied in small trials. A randomized controlled trial published in the Journal of Dermatological Treatment found that topical spironolactone 5% cream applied twice daily reduced acne lesion counts compared to placebo, though the evidence base remains smaller than for oral dosing. New York compounding pharmacies can prepare this formulation with a prescription.
Pricing for compounded spironolactone varies widely. Some 503A pharmacies in New York offer compounded oral suspensions or topical creams for $20 to $60 per month, depending on the formulation, strength, and base. A small number of pharmacies that participate in discount or membership programs may offer compounded versions at minimal cost. Insurance generally does not cover compounded medications, so patients should compare the compounded price against the $15 average for commercially available generic tablets.
The New York State Board of Pharmacy conducts inspections of 503A facilities and enforces sterility and potency standards. Patients can verify a pharmacy's compounding license through the New York State Education Department's Office of the Professions license verification tool.
Telehealth Prescribing of Spironolactone in New York
Telehealth prescribing of spironolactone is fully legal in New York. The state's telehealth parity law, updated and made permanent following temporary COVID-era expansions, requires insurers to cover telehealth visits at the same rate as in-person consultations. This means a dermatology or primary care telehealth visit to obtain a spironolactone prescription should be covered by most plans.
Several telehealth platforms operating in New York prescribe spironolactone for acne, including Apostrophe, Nurx, Curology, and Hers. Visit costs on these platforms typically range from $20 to $50 if paying out of pocket, with some offering subscription models that include the medication. HealthRX also provides telehealth consultations for hormonal acne treatment.
New York requires that the prescribing clinician hold a valid New York medical license. Out-of-state providers prescribing via telehealth must be licensed in New York or participate in an interstate compact. Patients should verify that their telehealth provider is New York-licensed before their visit.
One advantage of the telehealth route: prescribers on these platforms frequently handle spironolactone PA submissions for patients whose insurance requires them. The administrative infrastructure is built into the workflow, which can save patients the back-and-forth that sometimes occurs with traditional office-based prescriptions.
Baseline lab work is often required before starting spironolactone. Most prescribers order a basic metabolic panel (BMP) to check potassium levels, since spironolactone is a potassium-sparing diuretic. A study in the Journal of the American Academy of Dermatology found that the risk of clinically significant hyperkalemia in healthy young women taking spironolactone for acne is very low (under 1%), but baseline and follow-up monitoring remains standard of care. Quest Diagnostics and Labcorp both have extensive networks across New York, and most telehealth platforms can order labs directly.
Discount Programs and Savings Cards
Several pathways can reduce spironolactone costs below the $15 average cash price in New York.
GoodRx and RxSaver coupons. These free-to-use platforms aggregate pharmacy discount pricing. GoodRx frequently shows spironolactone prices as low as $4 to $9 for a 30-day supply at participating New York pharmacies. The price varies by pharmacy, tablet strength, and quantity. Patients simply present the coupon code at the pharmacy counter. No insurance is needed.
Manufacturer savings programs. Pfizer does not currently offer a standalone branded savings card specifically for spironolactone, since the drug is available in generic form from multiple manufacturers. However, Pfizer's broader patient assistance programs may cover spironolactone for patients who meet income eligibility criteria (typically below 200% of the federal poverty level).
Mark Cuban Cost Plus Drugs. This online pharmacy offers generic spironolactone at a markup of 15% over wholesale acquisition cost plus a flat $5 dispensing fee, with $5 shipping. Prices for spironolactone 100 mg (30 tablets) through Cost Plus typically run $5 to $8 total. The pharmacy ships to New York addresses.
Pharmacy membership programs. Costco's member prescription program and Walmart's $4 generic list both include spironolactone. Costco does not require a Costco membership to use the pharmacy in New York (state law requires pharmacies to serve non-members). A 30-day supply of spironolactone 25 mg through Walmart's program costs $4.
340B pharmacies. Patients receiving care at federally qualified health centers (FQHCs) in New York, such as those operated by NYC Health + Hospitals, may access spironolactone at 340B-discounted prices, which can bring the cost to $0 to $5.
Dr. Jennifer Berman, a board-certified dermatologist, has noted: "Spironolactone is one of the most cost-effective treatments we have for hormonal acne in women. The generic pricing makes it accessible even for uninsured patients, which is not something we can say about most prescription acne medications."
Dosing, Monitoring, and Ongoing Costs
Most dermatologists start spironolactone for acne at 25 mg to 50 mg daily and titrate up to 100 mg to 200 mg daily based on response and tolerability. The Endocrine Society's clinical practice guidelines address anti-androgen therapy dosing in the context of androgen excess disorders.
At the most common acne dose of 100 mg daily, annual medication cost with a discount coupon runs roughly $48 to $180 depending on the pharmacy and coupon used. Add baseline labs (BMP: $15 to $50 with insurance, $30 to $80 cash-pay) and one to two follow-up labs in the first year, and the total annual out-of-pocket burden for an uninsured New York patient is typically under $300.
For comparison, a year of brand-name topical dapsone (Aczone) costs roughly $4,800 at list price. Oral isotretinoin with required iPLEDGE monitoring, monthly pregnancy tests, and labs runs $2,400 to $6,000 annually. Spironolactone's affordability profile is difficult to match among prescription acne therapies.
The medication is taken long-term for acne. Unlike isotretinoin, which is used in defined courses of 4 to 6 months, spironolactone's acne benefits persist only while the patient continues taking it. Discontinuation typically leads to acne recurrence within 3 to 6 months, according to data from a retrospective cohort analysis published in the British Journal of Dermatology. This means patients should factor in ongoing monthly costs when evaluating the treatment.
Side effects that may prompt additional clinical visits include breast tenderness (reported in roughly 17% of patients at 100 mg daily), menstrual irregularities, dizziness, and increased urination. These are generally manageable and dose-dependent. The potassium-monitoring requirement is the primary ongoing lab cost.
New York-Specific Regulatory Considerations
New York maintains some of the most consumer-protective pharmacy laws in the country. Several provisions directly affect spironolactone access and pricing.
Surprise bill protections. New York's surprise billing law covers pharmacy services obtained through insured plans, meaning patients cannot be balance-billed beyond their plan's cost-sharing for in-network prescriptions.
Prescription drug price transparency. New York's Drug Accountability Board, established under the Prescription Drug Price Gouging Prevention Act, monitors wholesale price increases exceeding 16% per year. Generic spironolactone has not triggered this threshold, but the oversight mechanism provides a backstop against sudden price spikes.
Mandatory generic substitution. Under New York Education Law Section 6816-a, pharmacists must dispense the generic equivalent of a prescribed drug unless the prescriber writes "DAW" (dispense as written) or the patient specifically requests the brand. For spironolactone, this means patients automatically receive the lowest-cost generic unless otherwise specified.
The New York State Department of Health also operates the Elderly Pharmaceutical Insurance Coverage (EPIC) program for residents aged 65 and older with income up to $75,000 (single) or $100,000 (married). EPIC covers spironolactone and can serve as a secondary payer after Medicare Part D, reducing or eliminating copays for older patients prescribed spironolactone for heart failure or hypertension.
Patients prescribed spironolactone for acne at doses of 100 mg daily should have serum potassium checked at baseline, at 4 to 6 weeks after initiation, and annually thereafter, per guidance from the American Academy of Dermatology.
Frequently asked questions
›How much does spironolactone cost in New York?
›Does New York Medicaid cover spironolactone?
›Is compounded spironolactone legal in New York?
›Can I get spironolactone via telehealth in New York?
›Which insurance plans cover spironolactone in New York?
›What's the cheapest way to get spironolactone in New York?
›Are there New York spironolactone discount programs?
›How does the Pfizer savings card work for spironolactone in New York?
›Do I need blood work before starting spironolactone in New York?
›Can men get spironolactone for acne in New York?
References
- Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18(2):169-191. https://pubmed.ncbi.nlm.nih.gov/28012219/
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
- Plovanich M, Weng QY, Mostaghimi A. Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne. JAMA Dermatol. 2015;151(9):941-944. https://pubmed.ncbi.nlm.nih.gov/25135650/
- Martin KA, Anderson RR, Chang RJ, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(4):1233-1257. https://pubmed.ncbi.nlm.nih.gov/29846104/
- Spironolactone FDA-approved labeling. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/
- Afzali BM, Yaghoobi E, Yaghoobi R, Bagherani N, Dabbagh MA. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial. J Dermatolog Treat. 2012;23(1):21-25. https://pubmed.ncbi.nlm.nih.gov/16766489/